What is the current valuation of the Nucleic Acid Therapeutics CDMO Market?

The market valuation was 8.01 USD Billion in 2024. Read More

What is the projected market size for the Nucleic Acid Therapeutics CDMO Market by 2035?

The market is projected to reach 28.62 USD Billion by 2035. Read More

What is the expected CAGR for the Nucleic Acid Therapeutics CDMO Market during the forecast period?

The expected CAGR for the market from 2025 to 2035 is 12.27%. Read More

Which technology segment is anticipated to show the highest growth in the Nucleic Acid Therapeutics CDMO Market?

The Gene Therapy segment is projected to grow from 2.5 USD Billion in 2024 to 9.0 USD Billion by 2035. Read More

What are the key applications driving the Nucleic Acid Therapeutics CDMO Market?

Key applications include Oncology, Genetic Disorders, and Infectious Diseases, with Oncology expected to grow from 1.6 USD Billion to 5.7 USD Billion. Read More

Who are the leading players in the Nucleic Acid Therapeutics CDMO Market?

Key players include Lonza, WuXi AppTec, Catalent, and Samsung Biologics. Read More

What product type is expected to dominate the Nucleic Acid Therapeutics CDMO Market?

mRNA is anticipated to dominate, growing from 2.5 USD Billion in 2024 to 9.0 USD Billion by 2035. Read More

How do end users influence the Nucleic Acid Therapeutics CDMO Market?

Pharmaceutical Companies are projected to increase their market share from 2.4 USD Billion to 8.6 USD Billion by 2035. Read More

What role do research institutions play in the Nucleic Acid Therapeutics CDMO Market?

Research Institutions are expected to grow from 1.2 USD Billion in 2024 to 4.3 USD Billion by 2035. Read More

What is the significance of the CRISPR-Cas9 technology in the Nucleic Acid Therapeutics CDMO Market?

CRISPR-Cas9 is projected to grow from 1.0 USD Billion in 2024 to 4.0 USD Billion by 2035, indicating its rising importance. Read More

Nucleic Acid Therapeutics CDMO Market

ID: MRFR/HC/31930-HCR

100 Pages

Rahul Gotadki

Last Updated: April 06, 2026

Nucleic Acid Therapeutics CDMO Market Research Report By Technology (Gene Editing, Gene Therapy, RNA Interference, CRISPR-Cas9, Antisense Oligonucleotides), By Product Type (Plasmid DNA, mRNA, siRNA, Antisense Oligonucleotides, Gene Therapy Vectors), By Application (Oncology, Genetic Disorders, Infectious Diseases, Cardiovascular Diseases, Neurological Disorders), By End User (Pharmaceutical Companies, Biotechnology Companies, Research Institutions, Academic Institutions) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Nucleic Acid Therapeutics CDMO Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)12.27%

2024 Market Size$ 8.01 Billion

2025 Market Size$ 8.99 Billion

2035 Market Size$ 28.62 Billion

Key Players

Lonza

WuXi AppTec

Catalent

Samsung Biologics

Boehringer Ingelheim

Fujifilm Diosynth Biotechnologies

Trends

Rising Demand for Personalized Medicine
Increased Outsourcing by Pharmaceutical Companies
Technological Advancements in Manufacturing Processes

Opportunities

Growing Investment in Biotechnology
Advancements in Delivery Technologies
Rising Prevalence of Genetic Disorders

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Technology (USD Billion)
  1. 4.1.1 Gene Editing
  2. 4.1.2 Gene Therapy
  3. 4.1.3 RNA Interference
  4. 4.1.4 CRISPR-Cas9
  5. 4.1.5 Antisense Oligonucleotides
2. 4.2 Healthcare, BY Product Type (USD Billion)
  1. 4.2.1 Plasmid DNA
  2. 4.2.2 mRNA
  3. 4.2.3 siRNA
  4. 4.2.4 Antisense Oligonucleotides
  5. 4.2.5 Gene Therapy Vectors
3. 4.3 Healthcare, BY Application (USD Billion)
  1. 4.3.1 Oncology
  2. 4.3.2 Genetic Disorders
  3. 4.3.3 Infectious Diseases
  4. 4.3.4 Cardiovascular Diseases
  5. 4.3.5 Neurological Disorders
4. 4.4 Healthcare, BY End User (USD Billion)
  1. 4.4.1 Pharmaceutical Companies
  2. 4.4.2 Biotechnology Companies
  3. 4.4.3 Research Institutions
  4. 4.4.4 Academic Institutions
5. 4.5 Healthcare, BY Region (USD Billion)
  1. 4.5.1 North America
    1. 4.5.1.1 US
    2. 4.5.1.2 Canada
  2. 4.5.2 Europe
    1. 4.5.2.1 Germany
    2. 4.5.2.2 UK
    3. 4.5.2.3 France
    4. 4.5.2.4 Russia
    5. 4.5.2.5 Italy
    6. 4.5.2.6 Spain
    7. 4.5.2.7 Rest of Europe
  3. 4.5.3 APAC
    1. 4.5.3.1 China
    2. 4.5.3.2 India
    3. 4.5.3.3 Japan
    4. 4.5.3.4 South Korea
    5. 4.5.3.5 Malaysia
    6. 4.5.3.6 Thailand
    7. 4.5.3.7 Indonesia
    8. 4.5.3.8 Rest of APAC
  4. 4.5.4 South America
    1. 4.5.4.1 Brazil
    2. 4.5.4.2 Mexico
    3. 4.5.4.3 Argentina
    4. 4.5.4.4 Rest of South America
  5. 4.5.5 MEA
    1. 4.5.5.1 GCC Countries
    2. 4.5.5.2 South Africa
    3. 4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Lonza (CH)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 WuXi AppTec (CN)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Catalent (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Samsung Biologics (KR)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Boehringer Ingelheim (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Fujifilm Diosynth Biotechnologies (JP)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 CordenPharma (DE)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Aldevron (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Genomatica (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY TECHNOLOGY
4. 6.4 US MARKET ANALYSIS BY PRODUCT TYPE
5. 6.5 US MARKET ANALYSIS BY APPLICATION
6. 6.6 US MARKET ANALYSIS BY END USER
7. 6.7 CANADA MARKET ANALYSIS BY TECHNOLOGY
8. 6.8 CANADA MARKET ANALYSIS BY PRODUCT TYPE
9. 6.9 CANADA MARKET ANALYSIS BY APPLICATION
10. 6.10 CANADA MARKET ANALYSIS BY END USER
11. 6.11 EUROPE MARKET ANALYSIS
12. 6.12 GERMANY MARKET ANALYSIS BY TECHNOLOGY
13. 6.13 GERMANY MARKET ANALYSIS BY PRODUCT TYPE
14. 6.14 GERMANY MARKET ANALYSIS BY APPLICATION
15. 6.15 GERMANY MARKET ANALYSIS BY END USER
16. 6.16 UK MARKET ANALYSIS BY TECHNOLOGY
17. 6.17 UK MARKET ANALYSIS BY PRODUCT TYPE
18. 6.18 UK MARKET ANALYSIS BY APPLICATION
19. 6.19 UK MARKET ANALYSIS BY END USER
20. 6.20 FRANCE MARKET ANALYSIS BY TECHNOLOGY
21. 6.21 FRANCE MARKET ANALYSIS BY PRODUCT TYPE
22. 6.22 FRANCE MARKET ANALYSIS BY APPLICATION
23. 6.23 FRANCE MARKET ANALYSIS BY END USER
24. 6.24 RUSSIA MARKET ANALYSIS BY TECHNOLOGY
25. 6.25 RUSSIA MARKET ANALYSIS BY PRODUCT TYPE
26. 6.26 RUSSIA MARKET ANALYSIS BY APPLICATION
27. 6.27 RUSSIA MARKET ANALYSIS BY END USER
28. 6.28 ITALY MARKET ANALYSIS BY TECHNOLOGY
29. 6.29 ITALY MARKET ANALYSIS BY PRODUCT TYPE
30. 6.30 ITALY MARKET ANALYSIS BY APPLICATION
31. 6.31 ITALY MARKET ANALYSIS BY END USER
32. 6.32 SPAIN MARKET ANALYSIS BY TECHNOLOGY
33. 6.33 SPAIN MARKET ANALYSIS BY PRODUCT TYPE
34. 6.34 SPAIN MARKET ANALYSIS BY APPLICATION
35. 6.35 SPAIN MARKET ANALYSIS BY END USER
36. 6.36 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY
37. 6.37 REST OF EUROPE MARKET ANALYSIS BY PRODUCT TYPE
38. 6.38 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
39. 6.39 REST OF EUROPE MARKET ANALYSIS BY END USER
40. 6.40 APAC MARKET ANALYSIS
41. 6.41 CHINA MARKET ANALYSIS BY TECHNOLOGY
42. 6.42 CHINA MARKET ANALYSIS BY PRODUCT TYPE
43. 6.43 CHINA MARKET ANALYSIS BY APPLICATION
44. 6.44 CHINA MARKET ANALYSIS BY END USER
45. 6.45 INDIA MARKET ANALYSIS BY TECHNOLOGY
46. 6.46 INDIA MARKET ANALYSIS BY PRODUCT TYPE
47. 6.47 INDIA MARKET ANALYSIS BY APPLICATION
48. 6.48 INDIA MARKET ANALYSIS BY END USER
49. 6.49 JAPAN MARKET ANALYSIS BY TECHNOLOGY
50. 6.50 JAPAN MARKET ANALYSIS BY PRODUCT TYPE
51. 6.51 JAPAN MARKET ANALYSIS BY APPLICATION
52. 6.52 JAPAN MARKET ANALYSIS BY END USER
53. 6.53 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY
54. 6.54 SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE
55. 6.55 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
56. 6.56 SOUTH KOREA MARKET ANALYSIS BY END USER
57. 6.57 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY
58. 6.58 MALAYSIA MARKET ANALYSIS BY PRODUCT TYPE
59. 6.59 MALAYSIA MARKET ANALYSIS BY APPLICATION
60. 6.60 MALAYSIA MARKET ANALYSIS BY END USER
61. 6.61 THAILAND MARKET ANALYSIS BY TECHNOLOGY
62. 6.62 THAILAND MARKET ANALYSIS BY PRODUCT TYPE
63. 6.63 THAILAND MARKET ANALYSIS BY APPLICATION
64. 6.64 THAILAND MARKET ANALYSIS BY END USER
65. 6.65 INDONESIA MARKET ANALYSIS BY TECHNOLOGY
66. 6.66 INDONESIA MARKET ANALYSIS BY PRODUCT TYPE
67. 6.67 INDONESIA MARKET ANALYSIS BY APPLICATION
68. 6.68 INDONESIA MARKET ANALYSIS BY END USER
69. 6.69 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY
70. 6.70 REST OF APAC MARKET ANALYSIS BY PRODUCT TYPE
71. 6.71 REST OF APAC MARKET ANALYSIS BY APPLICATION
72. 6.72 REST OF APAC MARKET ANALYSIS BY END USER
73. 6.73 SOUTH AMERICA MARKET ANALYSIS
74. 6.74 BRAZIL MARKET ANALYSIS BY TECHNOLOGY
75. 6.75 BRAZIL MARKET ANALYSIS BY PRODUCT TYPE
76. 6.76 BRAZIL MARKET ANALYSIS BY APPLICATION
77. 6.77 BRAZIL MARKET ANALYSIS BY END USER
78. 6.78 MEXICO MARKET ANALYSIS BY TECHNOLOGY
79. 6.79 MEXICO MARKET ANALYSIS BY PRODUCT TYPE
80. 6.80 MEXICO MARKET ANALYSIS BY APPLICATION
81. 6.81 MEXICO MARKET ANALYSIS BY END USER
82. 6.82 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY
83. 6.83 ARGENTINA MARKET ANALYSIS BY PRODUCT TYPE
84. 6.84 ARGENTINA MARKET ANALYSIS BY APPLICATION
85. 6.85 ARGENTINA MARKET ANALYSIS BY END USER
86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE
88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
90. 6.90 MEA MARKET ANALYSIS
91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY
92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT TYPE
93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY END USER
95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY
96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT TYPE
97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY END USER
99. 6.99 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY
100. 6.100 REST OF MEA MARKET ANALYSIS BY PRODUCT TYPE
101. 6.101 REST OF MEA MARKET ANALYSIS BY APPLICATION
102. 6.102 REST OF MEA MARKET ANALYSIS BY END USER
103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
104. 6.104 RESEARCH PROCESS OF MRFR
105. 6.105 DRO ANALYSIS OF HEALTHCARE
106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
109. 6.109 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
110. 6.110 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
111. 6.111 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
112. 6.112 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
113. 6.113 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
114. 6.114 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
115. 6.115 HEALTHCARE, BY END USER, 2024 (% SHARE)
116. 6.116 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.2.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.2.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.2.4 BY END USER, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.3.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.3.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.3.4 BY END USER, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.4.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.4.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.4.4 BY END USER, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.5.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.5.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.5.4 BY END USER, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.6.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.6.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.6.4 BY END USER, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.7.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.7.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.7.4 BY END USER, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.8.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.8.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.8.4 BY END USER, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.9.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.9.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.9.4 BY END USER, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.10.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.10.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.10.4 BY END USER, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.11.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.11.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.11.4 BY END USER, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.12.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.12.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.12.4 BY END USER, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.13.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.13.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.13.4 BY END USER, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.14.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.14.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.14.4 BY END USER, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.15.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.15.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.15.4 BY END USER, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.16.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.16.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.16.4 BY END USER, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.17.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.17.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.17.4 BY END USER, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.18.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.18.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.18.4 BY END USER, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.19.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.19.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.19.4 BY END USER, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.20.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.20.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.20.4 BY END USER, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.21.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.21.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.21.4 BY END USER, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.22.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.22.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.22.4 BY END USER, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.23.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.23.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.23.4 BY END USER, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.24.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.24.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.24.4 BY END USER, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.25.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.25.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.25.4 BY END USER, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.26.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.26.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.26.4 BY END USER, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.27.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.27.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.27.4 BY END USER, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.28.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.28.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.28.4 BY END USER, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.29.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.29.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.29.4 BY END USER, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.30.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  3. 7.30.3 BY APPLICATION, 2025-2035 (USD Billion)
  4. 7.30.4 BY END USER, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Nucleic Acid Therapeutics CDMO Market Segmentation

Nucleic Acid Therapeutics CDMO Market By Technology (USD Billion, 2025-2035)

Gene Editing
Gene Therapy
RNA Interference
CRISPR-Cas9
Antisense Oligonucleotides

Nucleic Acid Therapeutics CDMO Market By Product Type (USD Billion, 2025-2035)

Plasmid DNA
mRNA
siRNA
Antisense Oligonucleotides
Gene Therapy Vectors

Nucleic Acid Therapeutics CDMO Market By Application (USD Billion, 2025-2035)

Oncology
Genetic Disorders
Infectious Diseases
Cardiovascular Diseases
Neurological Disorders

Nucleic Acid Therapeutics CDMO Market By End User (USD Billion, 2025-2035)

Pharmaceutical Companies
Biotechnology Companies
Research Institutions
Academic Institutions

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”